Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells
Open Access
- 6 June 2005
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 201 (11), 1837-1852
- https://doi.org/10.1084/jem.20042101
Abstract
Pre–B cells undergo apoptosis unless they are rescued by pre–B cell receptor–dependent survival signals. We previously showed that the BCR-ABL1 kinase that is expressed in pre–B lymphoblastic leukemia bypasses selection for pre–B cell receptor–dependent survival signals. Investigating possible interference of BCR-ABL1 with pre–B cell receptor signaling, we found that neither SYK nor SLP65 can be phosphorylated in response to pre–B cell receptor engagement. Instead, Bruton's tyrosine kinase (BTK) is constitutively phosphorylated by BCR-ABL1. Activated BTK is essential for survival signals that otherwise would arise from the pre–B cell receptor, including activation of PLCγ1, autonomous Ca2+ signaling, STAT5-phosphorylation, and up-regulation of BCLXL. Inhibition of BTK activity specifically induces apoptosis in BCR-ABL1+ leukemia cells to a similar extent as inhibition of BCR-ABL1 kinase activity itself. However, BCR-ABL1 cannot directly bind to full-length BTK. Instead, BCR-ABL1 induces the expression of a truncated splice variant of BTK that acts as a linker between the two kinases. As opposed to full-length BTK, truncated BTK lacks kinase activity yet can bind to BCR-ABL1 through its SRC-homology domain 3. Acting as a linker, truncated BTK enables BCR-ABL1–dependent activation of full-length BTK, which initiates downstream survival signals and mimics a constitutively active pre–B cell receptor.Keywords
This publication has 37 references indexed in Scilit:
- The BCR-ABL1 Kinase Bypasses Selection for the Expression of a Pre–B Cell Receptor in Pre–B Acute Lymphoblastic Leukemia CellsThe Journal of Experimental Medicine, 2004
- Bruton's Tyrosine Kinase Cooperates with the B Cell Linker Protein SLP-65 as a Tumor Suppressor in Pre-B CellsThe Journal of Experimental Medicine, 2003
- Defective Expression of Bruton's Tyrosine Kinase in Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 2003
- Phosphorylation of Bruton’s tyrosine kinase by c-AblBiochemical and Biophysical Research Communications, 2002
- Silencing of B Cell Receptor Signals in Human Naive B CellsThe Journal of Experimental Medicine, 2002
- Competing modes of self‐association in the regulatory domains of Bruton's tyrosine kinase: Intramolecular contact versus asymmetric homodimerizationProtein Science, 2002
- Competing modes of self-association in the regulatory domains of Bruton's tyrosine kinase: Intramolecular contact versus asymmetric homodimerizationProtein Science, 2002
- Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B CellsPublished by Elsevier BV ,2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- Cellular Origin of Human B-Cell LymphomasNew England Journal of Medicine, 1999